Pierre F Sabouret Shares A Study on the Risk of Cardiovascular Death in SIDs
Pierre F Sabouret, Member of the Executive Committee for Education at European Atherosclerosis Society, shared on LinkedIn:
”On pubmed today.
Number 28 in 2025 (same result as in 2024 reached in the last days of the year).
Grateful to have some friends to publish interesting (at least in my view) topics.”
This systematic review and meta-analysis of 39 observational studies involving 171,748 patients found that systemic immune-mediated diseases (SIDs) were associated with a significantly increased risk of cardiovascular death.
The association was particularly strong in patients with rheumatoid arthritis, systemic lupus erythematosus, and granulomatosis with polyangiitis, and was more pronounced among women.
Most cardiovascular deaths were attributable to acute coronary syndrome, with a 34% higher risk observed in SID patients.
Despite substantial heterogeneity and the observational nature of the data, the findings highlight the need for improved cardiovascular risk assessment in these populations.
Read the full article here.
Article: The risk of cardiovascular death in systemic immune-mediated diseases: A systematic review and meta-analysis
Authors: Stefano Figliozzi, Thanakorn Rojanathagoon, Spyridoula Karogianni, Lorenzo Cambini, Marco Bernardi, Cristina Panico, Fabrizio Ricci, Maria De Santis, Antonio Cannatà, Marinos Kallikourdis, Sebastiano Sciarretta, Giulio Stefanini, Mamas A. Mamas, Gianluigi Condorelli, Pierre F. Sabouret, Georgios Georgiopoulos
Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications